acetaminophen has been researched along with Apoplexy in 56 studies
Acetaminophen: Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
paracetamol : A member of the class of phenols that is 4-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group.
Excerpt | Relevance | Reference |
---|---|---|
"PAIS 2 (Paracetamol [Acetaminophen] in Stroke 2) was a multicenter, randomized, double-blind, placebo-controlled clinical trial." | 9.24 | PAIS 2 (Paracetamol [Acetaminophen] in Stroke 2): Results of a Randomized, Double-Blind Placebo-Controlled Clinical Trial. ( Algra, A; de Ridder, IR; den Hertog, HM; Dippel, DW; Jansen, BP; Kappelle, LJ; Koudstaal, PJ; Maasland, EL; Ruitenberg, A; Saxena, R; Schreuder, AH; Van den Berg-Vos, RM; van der Worp, HB; van Gemert, HM; van Tuijl, JH; Vermeij, F, 2017) |
"The Paracetamol (Acetaminophen) In Stroke 2 trial is a multicenter, randomized, double-blind, placebo-controlled clinical trial." | 9.20 | Paracetamol (Acetaminophen) in stroke 2 (PAIS 2): protocol for a randomized, placebo-controlled, double-blind clinical trial to assess the effect of high-dose paracetamol on functional outcome in patients with acute stroke and a body temperature of 36.5 ° ( Algra, A; de Jong, FJ; de Ridder, IR; den Hertog, HM; Dippel, DW; Kappelle, LJ; Koudstaal, PJ; Lingsma, HF; Maasland, EL; Oomes, P; Ruitenberg, A; Saxena, R; Schreuder, AH; van der Worp, HB; van Gemert, HM; van Tuijl, J, 2015) |
"The Paracetamol (Acetaminophen) In Stroke (PAIS) study is a phase III multicenter, double blind, randomized, placebo-controlled clinical trial of high-dose acetaminophen in patients with acute stroke." | 9.13 | Correction: PAIS: paracetamol (acetaminophen) in stroke; protocol for a randomized, double blind clinical trial. [ISCRTN74418480]. ( Algra, A; den Hertog, HM; Dippel, DW; Kappelle, LJ; Koudstaal, PJ; van der Worp, HB; van Gemert, HM; van Gijn, J, 2008) |
"In the majority of patients with acute ischemic stroke, ASA and acetaminophen are insufficient for reducing an elevated BT to a state of normothermia." | 9.11 | Acetylsalicylic acid and acetaminophen to combat elevated body temperature in acute ischemic stroke. ( De Keyser, J; Elting, JW; Luijckx, GJ; Luyckx, GJ; Maurits, N; Sulter, G, 2004) |
"The authors assessed the time of onset of the hypothermic effect of acetaminophen in 102 patients with acute ischemic stroke." | 9.10 | Timing of the effect of acetaminophen on body temperature in patients with acute ischemic stroke. ( Algra, A; Dippel, DW; Kappelle, LJ; Koudstaal, PJ; van Breda, EJ; van der Worp, HB; van Gemert, HM, 2003) |
"Treatment with a daily dose of 6000 mg acetaminophen results in a small, but potentially worthwhile decrease in body temperature after acute ischemic stroke, even in normothermic and subfebrile patients." | 9.10 | Effect of paracetamol (acetaminophen) and ibuprofen on body temperature in acute ischemic stroke PISA, a phase II double-blind, randomized, placebo-controlled trial [ISRCTN98608690]. ( Dippel, DW; Kappelle, LJ; Koudstaal, PJ; Meijer, RJ; van Breda, EJ; van der Worp, HB; van Gemert, HM, 2003) |
"Early administration of acetaminophen (3900 mg/d) to afebrile patients with acute stroke may result in a small reduction in CBT." | 9.10 | Acetaminophen for altering body temperature in acute stroke: a randomized clinical trial. ( Chalela, JA; Grotta, JC; Kasner, SE; Kimmel, SE; Krieger, DW; Morgenstern, LB; Piriyawat, P; Villar-Cordova, CE; Wein, T, 2002) |
"Treatment with a daily dose of 6000 mg acetaminophen may result in a small, but potentially beneficial, decrease in body temperature shortly after ischemic stroke, even in normothermic and subfebrile patients." | 9.09 | Effect of paracetamol (acetaminophen) on body temperature in acute ischemic stroke: a double-blind, randomized phase II clinical trial. ( Dippel, DW; Kappelle, LJ; Koudstaal, PJ; Meijer, RJ; van Breda, EJ; van der Worp, HB; van Gemert, HM, 2001) |
"Acetaminophen showed some capability to decrease body temperature for acute stroke." | 8.95 | Effect of paracetamol (acetaminophen) on body temperature in acute stroke: A meta-analysis. ( Chen, C; Cheng, H; Fang, J; Ma, L; Wang, R, 2017) |
"The aim was to assess whether using LSPS matching would enable the evaluation of paracetamol, compared to ibuprofen, and increased risk of myocardial infarction, stroke, gastrointestinal (GI) bleeding, or acute renal failure." | 7.96 | Channeling Bias in the Analysis of Risk of Myocardial Infarction, Stroke, Gastrointestinal Bleeding, and Acute Renal Failure with the Use of Paracetamol Compared with Ibuprofen. ( Berlin, JA; Fife, D; Ryan, PB; Schuemie, MJ; Swerdel, J; Weinstein, RB, 2020) |
" We determined whether paracetamol or ibuprofen use is associated with major cardiovascular events (MACE) or major bleeding in 19 120 patients with recent ischemic stroke or transient ischemic attack of mainly atherothrombotic origin included in the Prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) trial." | 7.83 | Paracetamol, Ibuprofen, and Recurrent Major Cardiovascular and Major Bleeding Events in 19 120 Patients With Recent Ischemic Stroke. ( Amarenco, P; Bousser, MG; Chamorro, A; Fisher, M; Ford, I; Fox, KM; Gonzalez-Valcarcel, J; Hennerici, MG; Labreuche, J; Mattle, HP; Rothwell, PM; Sissani, L; Steg, PG; Vicaut, E, 2016) |
"Oral tramadol/acetaminophen medication was effective at reducing pain levels in patients with CPSP, and is a medication option for the treatment of CPSP." | 7.79 | [Efficacy of tramadol/acetaminophen medication for central post-stroke pain]. ( Hirano, M; Kajita, Y; Nakahara, N; Noda, H; Takebayashi, S; Tanei, T; Wakabayashi, T, 2013) |
" Acetaminophen has been tried in stroke patients to produce hypothermia so that injury following cerebral ischemia can be reduced." | 7.76 | Endothelin-A receptor antagonist BQ123 potentiates acetaminophen induced hypothermia and reduces infarction following focal cerebral ischemia in rats. ( Briyal, S; Gulati, A, 2010) |
"Paracetamol (Acetaminophen) In Stroke (PAIS) is a randomized, double-blind clinical trial, comparing high-dose acetaminophen with placebo in 2500 patients." | 7.73 | PAIS: paracetamol (acetaminophen) in stroke; protocol for a randomized, double blind clinical trial [ISCRTN 74418480]. ( Algra, A; Dippel, DW; Kappelle, LJ; Koudstaal, PJ; van Breda, EJ; van der Worp, HB; van Gemert, HM; van Gijn, J, 2005) |
"Seventy-five (3 x 25) patients with acute ischaemic stroke confined to the anterior circulation will be randomised to treatment with either: 400 mg ibuprofen, 1000 mg acetaminophen, or with placebo 6 times daily during 5 days." | 7.71 | PISA. The effect of paracetamol (acetaminophen) and ibuprofen on body temperature in acute stroke: protocol for a phase II double-blind randomised placebo-controlled trial [ISRCTN98608690]. ( Dippel, DW; Kappelle, J; Koudstaal, PJ; Meijer, R; van Breda, EJ; van der Worp, B; van Gemert, M, 2002) |
"Acetaminophen exposure was a time-dependent variable." | 5.42 | Acetaminophen use and risk of myocardial infarction and stroke in a hypertensive cohort. ( Dawson, J; Dominiczak, AF; Fulton, RL; McInnes, GT; Meredith, PA; Morrison, DS; Morton, R; Padmanabhan, S; Touyz, RM; Walters, MR, 2015) |
"PAIS 2 (Paracetamol [Acetaminophen] in Stroke 2) was a multicenter, randomized, double-blind, placebo-controlled clinical trial." | 5.24 | PAIS 2 (Paracetamol [Acetaminophen] in Stroke 2): Results of a Randomized, Double-Blind Placebo-Controlled Clinical Trial. ( Algra, A; de Ridder, IR; den Hertog, HM; Dippel, DW; Jansen, BP; Kappelle, LJ; Koudstaal, PJ; Maasland, EL; Ruitenberg, A; Saxena, R; Schreuder, AH; Van den Berg-Vos, RM; van der Worp, HB; van Gemert, HM; van Tuijl, JH; Vermeij, F, 2017) |
"The Paracetamol (Acetaminophen) In Stroke 2 trial is a multicenter, randomized, double-blind, placebo-controlled clinical trial." | 5.20 | Paracetamol (Acetaminophen) in stroke 2 (PAIS 2): protocol for a randomized, placebo-controlled, double-blind clinical trial to assess the effect of high-dose paracetamol on functional outcome in patients with acute stroke and a body temperature of 36.5 ° ( Algra, A; de Jong, FJ; de Ridder, IR; den Hertog, HM; Dippel, DW; Kappelle, LJ; Koudstaal, PJ; Lingsma, HF; Maasland, EL; Oomes, P; Ruitenberg, A; Saxena, R; Schreuder, AH; van der Worp, HB; van Gemert, HM; van Tuijl, J, 2015) |
"The Paracetamol (Acetaminophen) In Stroke (PAIS) study is a phase III multicenter, double blind, randomized, placebo-controlled clinical trial of high-dose acetaminophen in patients with acute stroke." | 5.13 | Correction: PAIS: paracetamol (acetaminophen) in stroke; protocol for a randomized, double blind clinical trial. [ISCRTN74418480]. ( Algra, A; den Hertog, HM; Dippel, DW; Kappelle, LJ; Koudstaal, PJ; van der Worp, HB; van Gemert, HM; van Gijn, J, 2008) |
"In the majority of patients with acute ischemic stroke, ASA and acetaminophen are insufficient for reducing an elevated BT to a state of normothermia." | 5.11 | Acetylsalicylic acid and acetaminophen to combat elevated body temperature in acute ischemic stroke. ( De Keyser, J; Elting, JW; Luijckx, GJ; Luyckx, GJ; Maurits, N; Sulter, G, 2004) |
"The authors assessed the time of onset of the hypothermic effect of acetaminophen in 102 patients with acute ischemic stroke." | 5.10 | Timing of the effect of acetaminophen on body temperature in patients with acute ischemic stroke. ( Algra, A; Dippel, DW; Kappelle, LJ; Koudstaal, PJ; van Breda, EJ; van der Worp, HB; van Gemert, HM, 2003) |
"Treatment with a daily dose of 6000 mg acetaminophen results in a small, but potentially worthwhile decrease in body temperature after acute ischemic stroke, even in normothermic and subfebrile patients." | 5.10 | Effect of paracetamol (acetaminophen) and ibuprofen on body temperature in acute ischemic stroke PISA, a phase II double-blind, randomized, placebo-controlled trial [ISRCTN98608690]. ( Dippel, DW; Kappelle, LJ; Koudstaal, PJ; Meijer, RJ; van Breda, EJ; van der Worp, HB; van Gemert, HM, 2003) |
"Early administration of acetaminophen (3900 mg/d) to afebrile patients with acute stroke may result in a small reduction in CBT." | 5.10 | Acetaminophen for altering body temperature in acute stroke: a randomized clinical trial. ( Chalela, JA; Grotta, JC; Kasner, SE; Kimmel, SE; Krieger, DW; Morgenstern, LB; Piriyawat, P; Villar-Cordova, CE; Wein, T, 2002) |
"Treatment with a daily dose of 6000 mg acetaminophen may result in a small, but potentially beneficial, decrease in body temperature shortly after ischemic stroke, even in normothermic and subfebrile patients." | 5.09 | Effect of paracetamol (acetaminophen) on body temperature in acute ischemic stroke: a double-blind, randomized phase II clinical trial. ( Dippel, DW; Kappelle, LJ; Koudstaal, PJ; Meijer, RJ; van Breda, EJ; van der Worp, HB; van Gemert, HM, 2001) |
"Acetaminophen showed some capability to decrease body temperature for acute stroke." | 4.95 | Effect of paracetamol (acetaminophen) on body temperature in acute stroke: A meta-analysis. ( Chen, C; Cheng, H; Fang, J; Ma, L; Wang, R, 2017) |
"The aim was to assess whether using LSPS matching would enable the evaluation of paracetamol, compared to ibuprofen, and increased risk of myocardial infarction, stroke, gastrointestinal (GI) bleeding, or acute renal failure." | 3.96 | Channeling Bias in the Analysis of Risk of Myocardial Infarction, Stroke, Gastrointestinal Bleeding, and Acute Renal Failure with the Use of Paracetamol Compared with Ibuprofen. ( Berlin, JA; Fife, D; Ryan, PB; Schuemie, MJ; Swerdel, J; Weinstein, RB, 2020) |
" We determined whether paracetamol or ibuprofen use is associated with major cardiovascular events (MACE) or major bleeding in 19 120 patients with recent ischemic stroke or transient ischemic attack of mainly atherothrombotic origin included in the Prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) trial." | 3.83 | Paracetamol, Ibuprofen, and Recurrent Major Cardiovascular and Major Bleeding Events in 19 120 Patients With Recent Ischemic Stroke. ( Amarenco, P; Bousser, MG; Chamorro, A; Fisher, M; Ford, I; Fox, KM; Gonzalez-Valcarcel, J; Hennerici, MG; Labreuche, J; Mattle, HP; Rothwell, PM; Sissani, L; Steg, PG; Vicaut, E, 2016) |
"Oral tramadol/acetaminophen medication was effective at reducing pain levels in patients with CPSP, and is a medication option for the treatment of CPSP." | 3.79 | [Efficacy of tramadol/acetaminophen medication for central post-stroke pain]. ( Hirano, M; Kajita, Y; Nakahara, N; Noda, H; Takebayashi, S; Tanei, T; Wakabayashi, T, 2013) |
" Acetaminophen has been tried in stroke patients to produce hypothermia so that injury following cerebral ischemia can be reduced." | 3.76 | Endothelin-A receptor antagonist BQ123 potentiates acetaminophen induced hypothermia and reduces infarction following focal cerebral ischemia in rats. ( Briyal, S; Gulati, A, 2010) |
"Paracetamol (Acetaminophen) In Stroke (PAIS) is a randomized, double-blind clinical trial, comparing high-dose acetaminophen with placebo in 2500 patients." | 3.73 | PAIS: paracetamol (acetaminophen) in stroke; protocol for a randomized, double blind clinical trial [ISCRTN 74418480]. ( Algra, A; Dippel, DW; Kappelle, LJ; Koudstaal, PJ; van Breda, EJ; van der Worp, HB; van Gemert, HM; van Gijn, J, 2005) |
"Seventy-five (3 x 25) patients with acute ischaemic stroke confined to the anterior circulation will be randomised to treatment with either: 400 mg ibuprofen, 1000 mg acetaminophen, or with placebo 6 times daily during 5 days." | 3.71 | PISA. The effect of paracetamol (acetaminophen) and ibuprofen on body temperature in acute stroke: protocol for a phase II double-blind randomised placebo-controlled trial [ISRCTN98608690]. ( Dippel, DW; Kappelle, J; Koudstaal, PJ; Meijer, R; van Breda, EJ; van der Worp, B; van Gemert, M, 2002) |
"Severe infarcts and intracerebral hemorrhages caused temperature to rise, whereas initially increased temperature had no influence on stroke severity." | 2.70 | Stroke severity determines body temperature in acute stroke. ( Boysen, G; Christensen, H, 2001) |
" A recent systematic review found increased adverse events and mortality at therapeutic dosage." | 1.51 | Acetaminophen Safety: Risk of Mortality and Cardiovascular Events in Nursing Home Residents, a Prospective Study. ( Cantet, C; de Souto Barreto, P; Girard, P; Rolland, Y; Sourdet, S, 2019) |
"Migraine was present in 226 (75." | 1.43 | CADASIL: Migraine, Encephalopathy, Stroke and Their Inter-Relationships. ( Markus, HS; Tan, RY, 2016) |
"Acetaminophen exposure was a time-dependent variable." | 1.42 | Acetaminophen use and risk of myocardial infarction and stroke in a hypertensive cohort. ( Dawson, J; Dominiczak, AF; Fulton, RL; McInnes, GT; Meredith, PA; Morrison, DS; Morton, R; Padmanabhan, S; Touyz, RM; Walters, MR, 2015) |
"Compared to conventional treatment, fever burden was significantly lower within the first 4 days after admission (p < 0." | 1.37 | Standardized antipyretic treatment in stroke: a pilot study. ( Beck, A; Breuer, L; Kallmünzer, B; Köhrmann, M; Kollmar, R; Krause, C; Pauli, E, 2011) |
"Fever in acute stroke is associated with poor prognosis, but evidence-based recommendations on antipyretic therapy are lacking." | 1.36 | [Antipyretic strategies for acute stroke: a nationwide survey among German stroke units]. ( Beck, A; Kallmünzer, B; Kollmar, R; Schwab, S, 2010) |
" The drug's effect as well as adverse effects should be actively sought, and dosage alterations made in order to enhance the drug's effect." | 1.32 | Introduction to monitoring. What is what you prescribed actually doing? ( George, A; Shakib, S, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 25 (44.64) | 29.6817 |
2010's | 30 (53.57) | 24.3611 |
2020's | 1 (1.79) | 2.80 |
Authors | Studies |
---|---|
Friesen, RW | 1 |
Mancini, JA | 1 |
Lai, SW | 1 |
Lin, CL | 1 |
Girard, P | 2 |
Cantet, C | 2 |
Rolland, Y | 2 |
Weinstein, RB | 1 |
Ryan, PB | 1 |
Berlin, JA | 1 |
Schuemie, MJ | 1 |
Swerdel, J | 1 |
Fife, D | 1 |
Fang, J | 1 |
Chen, C | 1 |
Cheng, H | 1 |
Wang, R | 1 |
Ma, L | 1 |
de Ridder, IR | 4 |
Dippel, DWJ | 1 |
van der Worp, HB | 17 |
Noubiap, JJ | 1 |
Kamtchum-Tatuene, J | 1 |
Raza, SA | 1 |
Durm, LB | 1 |
Mahmoud, GA | 1 |
Rahman, H | 1 |
Henriquez, L | 1 |
Davis, B | 1 |
Nahab, F | 1 |
Sourdet, S | 1 |
de Souto Barreto, P | 1 |
Frank, B | 1 |
Fulton, RL | 2 |
Weimar, C | 1 |
Lees, KR | 1 |
Sanders, RD | 1 |
de Ridder, I | 1 |
den Hertog, H | 1 |
van Gemert, M | 2 |
Dippel, D | 1 |
van der Worp, B | 2 |
de Jong, FJ | 1 |
den Hertog, HM | 9 |
Lingsma, HF | 1 |
van Gemert, HM | 15 |
Schreuder, AH | 3 |
Ruitenberg, A | 3 |
Maasland, EL | 3 |
Saxena, R | 3 |
Oomes, P | 1 |
van Tuijl, J | 1 |
Koudstaal, PJ | 13 |
Kappelle, LJ | 11 |
Algra, A | 9 |
Dippel, DW | 17 |
Tanei, T | 1 |
Kajita, Y | 1 |
Noda, H | 1 |
Takebayashi, S | 1 |
Hirano, M | 1 |
Nakahara, N | 1 |
Wakabayashi, T | 1 |
Saxena, MK | 1 |
Taylor, CB | 1 |
Hammond, NE | 1 |
Young, PJ | 1 |
Seppelt, IM | 1 |
Glass, P | 1 |
Myburgh, JA | 1 |
Dumont, Z | 1 |
Mordasiewicz, M | 1 |
Kosar, L | 1 |
Schuster, B | 1 |
Drury, P | 1 |
Levi, C | 1 |
McInnes, E | 2 |
Hardy, J | 1 |
Ward, J | 1 |
Grimshaw, JM | 2 |
D' Este, C | 1 |
Dale, S | 2 |
McElduff, P | 1 |
Cheung, NW | 1 |
Quinn, C | 1 |
Griffiths, R | 1 |
Evans, M | 1 |
Cadilhac, D | 1 |
Middleton, S | 2 |
García-Poza, P | 1 |
de Abajo, FJ | 1 |
Gil, MJ | 1 |
Chacón, A | 1 |
Bryant, V | 1 |
García-Rodríguez, LA | 1 |
Walters, MR | 1 |
Morton, R | 1 |
Touyz, RM | 1 |
Dominiczak, AF | 1 |
Morrison, DS | 1 |
Padmanabhan, S | 1 |
Meredith, PA | 1 |
McInnes, GT | 1 |
Dawson, J | 1 |
Glasser, SP | 1 |
Khodneva, Y | 1 |
Gonzalez-Valcarcel, J | 1 |
Sissani, L | 1 |
Labreuche, J | 1 |
Bousser, MG | 1 |
Chamorro, A | 1 |
Fisher, M | 1 |
Ford, I | 1 |
Fox, KM | 1 |
Hennerici, MG | 1 |
Mattle, HP | 1 |
Rothwell, PM | 1 |
Steg, PG | 1 |
Vicaut, E | 1 |
Amarenco, P | 1 |
Tan, RY | 1 |
Markus, HS | 1 |
Iannuccelli, C | 1 |
Di Franco, M | 1 |
Pulcinelli, FM | 1 |
Craig, LE | 1 |
Churilov, L | 1 |
Olenko, L | 1 |
Cadilhac, DA | 1 |
Grimley, R | 1 |
Martinez-Garduno, C | 1 |
Considine, J | 1 |
van Tuijl, JH | 1 |
Jansen, BP | 1 |
Van den Berg-Vos, RM | 1 |
Vermeij, F | 1 |
van Gijn, J | 7 |
Tseng, MC | 1 |
Kasner, SE | 2 |
Kallmünzer, B | 2 |
Beck, A | 2 |
Schwab, S | 1 |
Kollmar, R | 2 |
Briyal, S | 1 |
Gulati, A | 1 |
Krause, C | 1 |
Pauli, E | 1 |
Breuer, L | 1 |
Köhrmann, M | 1 |
Meisel, A | 1 |
Wrotek, SE | 1 |
Kozak, WE | 1 |
Hess, DC | 1 |
Fagan, SC | 1 |
Takagi, K | 1 |
van Breda, EJ | 7 |
Meijer, RJ | 2 |
Shakib, S | 1 |
George, A | 1 |
Sulter, G | 1 |
Elting, JW | 1 |
Maurits, N | 1 |
Luijckx, GJ | 1 |
Luyckx, GJ | 1 |
De Keyser, J | 1 |
Wong, AA | 1 |
Davis, JP | 1 |
Schluter, PJ | 1 |
Henderson, RD | 1 |
O'Sullivan, JD | 1 |
Read, SJ | 1 |
Boysen, G | 1 |
Christensen, H | 1 |
Crome, P | 1 |
Rizeq, M | 1 |
George, S | 1 |
Braithwaite, RA | 1 |
Jones, PW | 1 |
Koennecke, HC | 2 |
Leistner, S | 1 |
Wein, T | 1 |
Piriyawat, P | 1 |
Villar-Cordova, CE | 1 |
Chalela, JA | 1 |
Krieger, DW | 1 |
Morgenstern, LB | 1 |
Kimmel, SE | 1 |
Grotta, JC | 1 |
Meijer, R | 1 |
Kappelle, J | 1 |
Ellrodt, A | 1 |
3 reviews available for acetaminophen and Apoplexy
Article | Year |
---|---|
Effect of paracetamol (acetaminophen) on body temperature in acute stroke: A meta-analysis.
Topics: Acetaminophen; Antipyretics; Body Temperature; Humans; Stroke | 2017 |
Cooling therapy for acute stroke.
Topics: Acetaminophen; Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Dipyrone; Humans; Hypothermia | 2009 |
Treatment of fever after stroke: conflicting evidence.
Topics: Acetaminophen; Animals; Antipyretics; Body Temperature; Fever; Humans; Severity of Illness Index; St | 2011 |
14 trials available for acetaminophen and Apoplexy
Article | Year |
---|---|
Increased benefit of alteplase in patients with ischemic stroke and a high body temperature.
Topics: Acetaminophen; Aged; Aged, 80 and over; Antipyretics; Body Temperature; Brain Ischemia; Double-Blind | 2013 |
Paracetamol (Acetaminophen) in stroke 2 (PAIS 2): protocol for a randomized, placebo-controlled, double-blind clinical trial to assess the effect of high-dose paracetamol on functional outcome in patients with acute stroke and a body temperature of 36.5 °
Topics: Acetaminophen; Antipyretics; Body Temperature; Clinical Protocols; Dose-Response Relationship, Drug; | 2015 |
Temperature management in patients with acute neurological lesions: an Australian and New Zealand point prevalence study.
Topics: Acetaminophen; Antipyretics; Australia; Body Temperature; Brain Injuries; Dose-Response Relationship | 2013 |
PAIS 2 (Paracetamol [Acetaminophen] in Stroke 2): Results of a Randomized, Double-Blind Placebo-Controlled Clinical Trial.
Topics: Acetaminophen; Aged; Aged, 80 and over; Antipyretics; Brain Ischemia; Cerebral Hemorrhage; Double-Bl | 2017 |
Correction: PAIS: paracetamol (acetaminophen) in stroke; protocol for a randomized, double blind clinical trial. [ISCRTN74418480].
Topics: Acetaminophen; Analgesics, Non-Narcotic; Clinical Protocols; Double-Blind Method; Fever; Humans; Log | 2008 |
The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial.
Topics: Acetaminophen; Aged; Anti-Inflammatory Agents, Non-Steroidal; Body Temperature; Brain Ischemia; Fema | 2009 |
Effect of paracetamol (acetaminophen) and ibuprofen on body temperature in acute ischemic stroke PISA, a phase II double-blind, randomized, placebo-controlled trial [ISRCTN98608690].
Topics: Acetaminophen; Acute Disease; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroida | 2003 |
Timing of the effect of acetaminophen on body temperature in patients with acute ischemic stroke.
Topics: Acetaminophen; Acute Disease; Aged; Body Temperature; Brain Ischemia; Double-Blind Method; Female; H | 2003 |
[Treatment of stroke by reducing the body temperature; 'Paracetamol (acetaminophen) in stroke' (PAIS): start of a clinical trial].
Topics: Acetaminophen; Acute Disease; Analgesics, Non-Narcotic; Body Temperature; Double-Blind Method; Fever | 2003 |
Acetylsalicylic acid and acetaminophen to combat elevated body temperature in acute ischemic stroke.
Topics: Acetaminophen; Acute Disease; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroida | 2004 |
Stroke severity determines body temperature in acute stroke.
Topics: Acetaminophen; Acute Disease; Aged; Aged, 80 and over; Anticoagulants; Body Temperature; Cerebral He | 2001 |
Effect of paracetamol (acetaminophen) on body temperature in acute ischemic stroke: a double-blind, randomized phase II clinical trial.
Topics: Acetaminophen; Acute Disease; Aged; Body Temperature; Brain Ischemia; Double-Blind Method; Female; F | 2001 |
Prophylactic antipyretic treatment with acetaminophen in acute ischemic stroke: a pilot study.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Brain Ischemia; Double-Blind Method; Female; Humans; | 2001 |
Acetaminophen for altering body temperature in acute stroke: a randomized clinical trial.
Topics: Acetaminophen; Acute Disease; Aged; Body Temperature; Double-Blind Method; Female; Fever; Humans; Hy | 2002 |
39 other studies available for acetaminophen and Apoplexy
Article | Year |
---|---|
Microsomal prostaglandin E2 synthase-1 (mPGES-1): a novel anti-inflammatory therapeutic target.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Atherosclerosis; Fever; Humans; Intramolecular Oxi | 2008 |
Acetaminophen Use and Stroke Risk.
Topics: Acetaminophen; Aged; Analgesics, Non-Narcotic; Humans; Incidence; Risk Assessment; Stroke; Taiwan | 2019 |
Reply to Acetaminophen Use and Stroke Risk.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Fever; Humans; Stroke | 2019 |
Channeling Bias in the Analysis of Risk of Myocardial Infarction, Stroke, Gastrointestinal Bleeding, and Acute Renal Failure with the Use of Paracetamol Compared with Ibuprofen.
Topics: Acetaminophen; Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Ag | 2020 |
Response by de Ridder et al to Letter Regarding Article, "PAIS 2 (Paracetamol [Acetaminophen] in Stroke 2) Results of a Randomized, Double-Blind Placebo-Controlled Clinical Trial".
Topics: Acetaminophen; Analgesics, Non-Narcotic; Double-Blind Method; Humans; Plasminogen Activator Inhibito | 2017 |
Letter by Noubiap and Kamtchum-Tatuene Regarding Article, "PAIS 2 (Paracetamol [Acetaminophen] in Stroke 2): Results of a Randomized, Double-Blind Placebo-Controlled Clinical Trial".
Topics: Acetaminophen; Analgesics, Non-Narcotic; Double-Blind Method; Humans; Plasminogen Activator Inhibito | 2017 |
Over-the-counter analgesic powder use in patients presenting with intracerebral hemorrhage: A case series.
Topics: Acetaminophen; Adult; Aged; Analgesics; Aspirin; Black or African American; Cerebral Hemorrhage; Dos | 2018 |
Acetaminophen Safety: Risk of Mortality and Cardiovascular Events in Nursing Home Residents, a Prospective Study.
Topics: Acetaminophen; Aged, 80 and over; Analgesics, Non-Narcotic; Female; France; Humans; Male; Mortality; | 2019 |
Use of paracetamol in ischaemic stroke patients: evidence from VISTA.
Topics: Acetaminophen; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Brain Ischemia; Female; Fever; Hum | 2013 |
[Efficacy of tramadol/acetaminophen medication for central post-stroke pain].
Topics: Acetaminophen; Aged; Female; Humans; Japan; Male; Middle Aged; Pain; Pain Measurement; Stroke; Trama | 2013 |
Warfarin: its highs and lows.
Topics: Acetaminophen; Aged, 80 and over; Analgesics, Non-Narcotic; Anticoagulants; Atrial Fibrillation; Cho | 2013 |
Management of fever, hyperglycemia, and swallowing dysfunction following hospital admission for acute stroke in New South Wales, Australia.
Topics: Acetaminophen; Aged; Aged, 80 and over; Antipyretics; Cohort Studies; Deglutition Disorders; Female; | 2014 |
Risk of ischemic stroke associated with non-steroidal anti-inflammatory drugs and paracetamol: a population-based case-control study.
Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Brain Ischem | 2015 |
Acetaminophen use and risk of myocardial infarction and stroke in a hypertensive cohort.
Topics: Acetaminophen; Aged; Analgesics, Non-Narcotic; Blood Pressure; Chronic Pain; Confounding Factors, Ep | 2015 |
Should acetaminophen be added to the list of anti-inflammatory agents that are associated with cardiovascular events?
Topics: Acetaminophen; Blood Pressure; Chronic Pain; Female; Humans; Hypertension; Male; Myocardial Infarcti | 2015 |
Paracetamol, Ibuprofen, and Recurrent Major Cardiovascular and Major Bleeding Events in 19 120 Patients With Recent Ischemic Stroke.
Topics: Acetaminophen; Aged; Analgesics, Non-Narcotic; Brain Ischemia; Cardiovascular Diseases; Female; Hemo | 2016 |
CADASIL: Migraine, Encephalopathy, Stroke and Their Inter-Relationships.
Topics: Acetaminophen; Adult; Age of Onset; Aged; Aged, 80 and over; Analgesics; CADASIL; Codeine; Cross-Sec | 2016 |
Letter by Iannuccelli et al Regarding Article, "Paracetamol, Ibuprofen, and Recurrent Major Cardiovascular and Major Bleeding Events in 19 120 Patients With Recent Ischemic Stroke".
Topics: Acetaminophen; Brain Ischemia; Hemorrhage; Humans; Ibuprofen; Stroke | 2016 |
Testing a systematic approach to identify and prioritise barriers to successful implementation of a complex healthcare intervention.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Australia; Emergency Medical Services; Emergency Ser | 2017 |
Paracetamol for stroke: easy in practice, but not in trials.
Topics: Acetaminophen; Anti-Inflammatory Agents; Clinical Trials as Topic; Humans; Hypothermia, Induced; Str | 2009 |
Confusion and stroke due to an "umbrella brand" product.
Topics: Acetaminophen; Canada; Diphenhydramine; Drug Combinations; Drug Labeling; France; Humans; Medication | 2008 |
High-dose paracetamol in stroke: new trials are necessary and feasible.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Body Temperature; Clinical Trials as Topic; Humans; Stroke | 2009 |
[Antipyretic strategies for acute stroke: a nationwide survey among German stroke units].
Topics: Acetaminophen; Analgesics, Non-Narcotic; Cryotherapy; Data Collection; Dipyrone; Germany; Hospitals, | 2010 |
Endothelin-A receptor antagonist BQ123 potentiates acetaminophen induced hypothermia and reduces infarction following focal cerebral ischemia in rats.
Topics: Acetaminophen; Animals; Antipyretics; Brain Ischemia; Disease Models, Animal; Drug Synergism; Endoth | 2010 |
An early rise in body temperature is related to unfavorable outcome after stroke: data from the PAIS study.
Topics: Acetaminophen; Aged; Antipyretics; Female; Fever; Humans; Male; Multicenter Studies as Topic; Random | 2011 |
Standardized antipyretic treatment in stroke: a pilot study.
Topics: Acetaminophen; Aged; Aged, 80 and over; Antipyretics; Body Temperature Regulation; Case-Control Stud | 2011 |
Effective fever control in acute stroke: still wanted!
Topics: Acetaminophen; Antipyretics; Body Temperature Regulation; Combined Modality Therapy; Dipyrone; Fever | 2011 |
Effects of high-dose paracetamol on blood pressure in acute stroke.
Topics: Acetaminophen; Aged; Aged, 80 and over; Antipyretics; Blood Pressure; Blood Pressure Determination; | 2012 |
[Does paracetamol improve recovery after stroke?].
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Fever; Hum | 2011 |
Body temperature in acute stroke.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Body Temperature; Disease Progression; Fever; Huma | 2002 |
Introduction to monitoring. What is what you prescribed actually doing?
Topics: Acetaminophen; Aged; Aspirin; Australia; Celecoxib; Drug Interactions; Drug Therapy, Combination; Fa | 2003 |
Reduction of body temperature with paracetamol in patients with acute stroke: randomised clinical trials are needed.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Fever; Hu | 2004 |
PAIS: paracetamol (acetaminophen) in stroke; protocol for a randomized, double blind clinical trial [ISCRTN 74418480].
Topics: Acetaminophen; Analgesics, Non-Narcotic; Body Temperature; Clinical Protocols; Double-Blind Method; | 2005 |
The time course and determinants of temperature within the first 48 h after ischaemic stroke.
Topics: Acetaminophen; Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Bacterial Infec | 2007 |
Acetaminophen for temperature reduction in acute stroke: potential but unproven benefits.
Topics: Acetaminophen; Acute Disease; Analgesics, Non-Narcotic; Body Temperature; Clinical Trials as Topic; | 2007 |
Drug absorption may be delayed after stroke: results of the paracetamol absorption test.
Topics: Acetaminophen; Administration, Oral; Analgesics, Non-Narcotic; Gastric Emptying; Humans; Intestinal | 2001 |
Modification of body temperature after acute stroke: a new concept needed?
Topics: Acetaminophen; Acute Disease; Body Temperature; Double-Blind Method; Fever; Humans; Hypothermia; Str | 2002 |
PISA. The effect of paracetamol (acetaminophen) and ibuprofen on body temperature in acute stroke: protocol for a phase II double-blind randomised placebo-controlled trial [ISRCTN98608690].
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Body Temperature; Clinical Trials, Phase II | 2002 |
Assessing the risks of cervical manipulation for neck pain.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Cervical Vertebrae; Evidence-Based Medicine; | 2002 |